NASDAQ •
Healthcare •
Medical Devices •
Quote as of 08/20/2026 12:46
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.98 mln
Float0.47 mln
Earnings Date11/18/2026
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
11
/ 100
Significantly lagging
Debt / Equity
0.07
Debt-free
ROE
-138
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Founded in 1984 and headquartered in San Diego, California, Aethlon Medical is working to bring a new kind of treatment device to patients fighting cancer or dangerous viral infections. The company's main product, the Hemopurifier, is currently in clinical trials and is also being explored for use in organ transplantation. By filtering harmful agents from the blood, this device aims to support the body's natural ability to fight disease.
